Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
16 02 2021
Historique:
received: 30 06 2020
accepted: 26 10 2020
revised: 13 10 2020
entrez: 16 2 2021
pubmed: 17 2 2021
medline: 29 6 2021
Statut: epublish

Résumé

Dopamine (DA) and norepinephrine (NE) are catecholamines primarily studied in the central nervous system that also act in the pancreas as peripheral regulators of metabolism. Pancreatic catecholamine signaling has also been increasingly implicated as a mechanism responsible for the metabolic disturbances produced by antipsychotic drugs (APDs). Critically, however, the mechanisms by which catecholamines modulate pancreatic hormone release are not completely understood. We show that human and mouse pancreatic α- and β-cells express the catecholamine biosynthetic and signaling machinery, and that α-cells synthesize DA de novo. This locally-produced pancreatic DA signals via both α- and β-cell adrenergic and dopaminergic receptors with different affinities to regulate glucagon and insulin release. Significantly, we show DA functions as a biased agonist at α

Identifiants

pubmed: 33589583
doi: 10.1038/s41398-020-01171-z
pii: 10.1038/s41398-020-01171-z
pmc: PMC7884786
doi:

Substances chimiques

Adrenergic Agents 0
Insulin 0
Glucagon 9007-92-5
Dopamine VTD58H1Z2X
Norepinephrine X4W3ENH1CV

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

59

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK097160
Pays : United States
Organisme : U.S. Department of Defense (United States Department of Defense)
ID : PR141292
Organisme : NIA NIH HHS
ID : R21 AG068607
Pays : United States
Organisme : NIDA NIH HHS
ID : K08 DA031241
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
ID : R01DK097160
Organisme : U.S. Department of Veterans Affairs (Department of Veterans Affairs)
ID : I01BX002678

Références

Mol Psychiatry. 2020 Sep;25(9):2070-2085
pubmed: 30626912
J Endocrinol. 2015 Mar;224(3):R123-30
pubmed: 25568163
Mol Endocrinol. 2015 Apr;29(4):542-57
pubmed: 25751312
Am J Med. 2008 Feb;121(2):98-104
pubmed: 18261494
Diabetes Obes Metab. 2018 Sep;20 Suppl 2:127-136
pubmed: 30230183
Mol Endocrinol. 2013 Aug;27(8):1198-207
pubmed: 23744894
Br J Pharmacol. 1997 Dec;122(8):1669-78
pubmed: 9422813
J Clin Invest. 1979 Feb;63(2):310-7
pubmed: 34629
Diabetes Obes Metab. 2014 Sep;16 Suppl 1:102-10
pubmed: 25200303
Front Neurosci. 2017 Jul 28;11:432
pubmed: 28804444
Neuroimmunomodulation. 2017;24(4-5):282-291
pubmed: 29514151
Diabetologia. 2018 Jan;61(1):168-181
pubmed: 28852792
Neuroendocrinology. 1993 Mar;57(3):476-80
pubmed: 8100618
Pharmacol Rev. 2017 Jul;69(3):256-297
pubmed: 28626043
Neuropsychiatr Dis Treat. 2017 Aug 22;13:2231-2241
pubmed: 28883731
J Biol Chem. 2018 Apr 20;293(16):5860-5877
pubmed: 29496998
J Clin Invest. 1974 Oct;54(4):833-41
pubmed: 4430717
Br J Pharmacol. 2015 Jan;172(1):1-23
pubmed: 25671228
Mol Pharmacol. 2015 Aug;88(2):335-46
pubmed: 26013541
J Clin Invest. 1979 Feb;63(2):230-8
pubmed: 34627
J Comp Neurol. 1975 Oct 15;163(4):467-505
pubmed: 1100685
Mol Pharmacol. 2016 Apr;89(4):457-66
pubmed: 26843180
Ups J Med Sci. 2016 May;121(2):120-32
pubmed: 27044660
Genome Res. 2017 Feb;27(2):208-222
pubmed: 27864352
Biochim Biophys Acta. 2016 Sep;1862(9):1485-94
pubmed: 27208795
Pancreas. 2015 Aug;44(6):925-9
pubmed: 25931261
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16009-12
pubmed: 20798346
Australas Psychiatry. 2018 Feb;26(1):92-94
pubmed: 29017334
J Biol Chem. 2005 Nov 4;280(44):36824-32
pubmed: 16129680
Psychoneuroendocrinology. 2017 Aug;82:38-45
pubmed: 28500893
Endocrinology. 2004 Feb;145(2):667-78
pubmed: 14592952
Am J Physiol Endocrinol Metab. 2000 Oct;279(4):E815-22
pubmed: 11001763
Minerva Endocrinol. 2016 Mar;41(1):43-56
pubmed: 26505694
J Comp Neurol. 2008 Dec 10;511(5):610-27
pubmed: 18924139
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Eur J Endocrinol. 2018 Jun;178(6):R267-R280
pubmed: 29678923
J Neural Transm Suppl. 1992;36:163-77
pubmed: 1527516
Diabetes. 1979 Oct;28(10):899-904
pubmed: 383555
Cell Metab. 2012 Dec 5;16(6):723-37
pubmed: 23217255
Tissue Cell. 1996 Feb;28(1):17-24
pubmed: 8907725
Best Pract Res Clin Endocrinol Metab. 2014 Oct;28(5):745-56
pubmed: 25256769
Semin Cell Dev Biol. 2020 Jul;103:41-50
pubmed: 31983511
Ups J Med Sci. 2016 May;121(2):113-9
pubmed: 27044683
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2334-9
pubmed: 16461897
Am J Transplant. 2003 Sep;3(9):1135-42
pubmed: 12919094
Adv Physiol Educ. 2013 Mar;37(1):53-60
pubmed: 23471249
Schizophr Res. 2011 Sep;131(1-3):90-5
pubmed: 21696923
Commun Biol. 2018 Sep 3;1:128
pubmed: 30272007
Bioorg Med Chem. 2016 Jun 15;24(12):2641-53
pubmed: 27132867
Mol Endocrinol. 2012 Nov;26(11):1928-40
pubmed: 22918877
Eur Neurol. 1976;14(3):229-39
pubmed: 1278195
Mol Neurobiol. 2018 Nov;55(11):8438-8454
pubmed: 29552726
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3242-6
pubmed: 8159732
Mol Metab. 2019 May;23:37-50
pubmed: 30876866
Acta Physiol Scand Suppl. 1974;412:1-48
pubmed: 4531814
Eur J Endocrinol. 2003 Oct;149(4):343-50
pubmed: 14514350
J Vis Exp. 2018 May 10;(135):
pubmed: 29806846
J Pharmacol Exp Ther. 1999 Jun;289(3):1286-92
pubmed: 10336518
J Endocrinol. 2015 Apr;225(1):19-26
pubmed: 25630331
Diabetes Res Clin Pract. 2014 Jan;103(1):1-10
pubmed: 24367972
J Chem Neuroanat. 2008 Mar;35(2):202-15
pubmed: 18155403
J Pharmacol Exp Ther. 2014 Oct;351(1):114-23
pubmed: 25073474
J Clin Endocrinol Metab. 1997 Nov;82(11):3864-71
pubmed: 9360553
Pharmacol Ther. 2019 Nov;203:107392
pubmed: 31299315
Neurosci Res. 2010 Jul;67(3):245-9
pubmed: 20302892
Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):177-84
pubmed: 21254289
J Clin Invest. 1973 Sep;52(9):2102-16
pubmed: 4727451
Biol Pharm Bull. 2018;41(8):1286-1290
pubmed: 30068879
Cell Metab. 2011 Jul 6;14(1):45-54
pubmed: 21723503
J Clin Endocrinol Metab. 1977 Dec;45(6):1154-8
pubmed: 591612
JAMA Intern Med. 2017 Feb 1;177(2):274-275
pubmed: 27942726
ACS Chem Neurosci. 2019 Aug 21;10(8):3590-3600
pubmed: 31313902
Clin Sci (Lond). 1997 Apr;92(4):423-30
pubmed: 9176043
J Pharmacol Sci. 2012;119(4):368-80
pubmed: 22850614
Mol Metab. 2016 May 03;5(7):449-458
pubmed: 27408771
Mol Endocrinol. 2012 Oct;26(10):1757-72
pubmed: 22915827
J Pharmacol Exp Ther. 2003 Jun;305(3):800-11
pubmed: 12649306
Histol Histopathol. 2002 Jan;17(1):113-21
pubmed: 11813861
Diabetes Obes Metab. 2014 Sep;16 Suppl 1:87-95
pubmed: 25200301
Semin Cell Dev Biol. 2013 Jan;24(1):11-21
pubmed: 23022232
Endocrinology. 2010 Apr;151(4):1441-50
pubmed: 20147524
Cell Metab. 2019 Mar 5;29(3):745-754.e4
pubmed: 30449685
Mol Pharmacol. 2002 Apr;61(4):729-37
pubmed: 11901210
Pharmacol Rev. 2004 Sep;56(3):331-49
pubmed: 15317907
Diabetes. 2013 Sep;62(9):3232-40
pubmed: 23835329
Nat Metab. 2020 Jan;2(1):32-40
pubmed: 31993555
Trends Endocrinol Metab. 2014 Nov;25(11):593-600
pubmed: 25190097
Cell Tissue Res. 2014 Sep;357(3):597-606
pubmed: 24825414
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
Neuroendocrinology. 2010;92(4):207-14
pubmed: 20975260
Am J Physiol. 1989 Feb;256(2 Pt 1):E284-7
pubmed: 2493196
Diabetologia. 1977 Apr;13(2):117-24
pubmed: 404204
CNS Drugs. 2020 May;34(5):473-507
pubmed: 32246399
J Transplant. 2012;2012:856386
pubmed: 23304445
Endocrinology. 2000 Jan;141(1):111-7
pubmed: 10614629
J Clin Endocrinol Metab. 1999 Jul;84(7):2523-31
pubmed: 10404831
Cell Rep. 2018 Mar 6;22(10):2667-2676
pubmed: 29514095
Arch Gen Psychiatry. 2002 Apr;59(4):337-45
pubmed: 11926934
PLoS One. 2016 Feb 05;11(2):e0148684
pubmed: 26849707
Diabetologia. 2008 Dec;51(12):2309-17
pubmed: 18843478
Diabetologia. 1980 Apr;18(4):341-6
pubmed: 6998806

Auteurs

Despoina Aslanoglou (D)

Translational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

Suzanne Bertera (S)

Institute of Cellular Therapeutics, Allegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, USA.

Marta Sánchez-Soto (M)

Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

R Benjamin Free (R)

Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Jeongkyung Lee (J)

Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Diabetes and Beta Cell Biology Center, University of Pittsburgh, Pittsburgh, PA, USA.

Wei Zong (W)

Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.

Xiangning Xue (X)

Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.

Shristi Shrestha (S)

Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Marcela Brissova (M)

Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Ryan W Logan (RW)

Translational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
Center for Systems Neurogenetics of Addiction, The Jackson Laboratory, Bar Harbor, ME, USA.

Claes B Wollheim (CB)

Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland.

Massimo Trucco (M)

Institute of Cellular Therapeutics, Allegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, USA.
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.
College of Medicine, Drexel University, Philadelphia, PA, USA.

Vijay K Yechoor (VK)

Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Diabetes and Beta Cell Biology Center, University of Pittsburgh, Pittsburgh, PA, USA.

David R Sibley (DR)

Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Rita Bottino (R)

Institute of Cellular Therapeutics, Allegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, USA.
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.
College of Medicine, Drexel University, Philadelphia, PA, USA.

Zachary Freyberg (Z)

Translational Neuroscience Program, Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA. freyberg@pitt.edu.
Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA. freyberg@pitt.edu.

Articles similaires

Cerebrospinal Fluid Animals Liver Glymphatic System Spinal Cord
Perylene Dopamine Electrochemical Techniques Imides Luminescent Measurements
Humans Insulin Resistance Muscle, Skeletal Oxidative Stress Oxidation-Reduction

Classifications MeSH